Serum interleukin 15 levels in patients with seropositive myasthenia gravis do not correlate with disease severity
Conclusions Serum interleukin 15 levels in patients with seropositive myasthenia gravis do not correlate with disease severity.
Source: Polish Journal of Neurology and Neurosurgery - Category: Neurosurgery Source Type: research
More News: Autoimmune Disease | Brain | Corticosteroid Therapy | Japan Health | Myasthenia Gravis | Neurology | Neurosurgery | Poland Health | Statistics | Women